Back to Search
Start Over
Differences in Colistin-resistantAcinetobacter baumanniiClinical Isolates Between Patients With and Without Prior Colistin Treatment
- Source :
- Annals of Laboratory Medicine
- Publication Year :
- 2018
- Publisher :
- Annals of Laboratory Medicine, 2018.
-
Abstract
- Background The increasing morbidity and mortality rates associated with Acinetobacter baumannii are due to the emergence of drug resistance and the limited treatment options. We compared characteristics of colistin-resistant Acinetobacter baumannii (CR-AB) clinical isolates recovered from patients with and without prior colistin treatment. We assessed whether prior colistin treatment affects the resistance mechanism of CR-AB isolates, mortality rates, and clinical characteristics. Additionally, a proper method for identifying CR-AB was determined. Methods We collected 36 non-duplicate CR-AB clinical isolates resistant to colistin. Antimicrobial susceptibility testing, Sanger sequencing analysis, molecular typing, lipid A structure analysis, and in vitro synergy testing were performed. Eleven colistin-susceptible AB isolates were used as controls. Results Despite no differences in clinical characteristics between patients with and without prior colistin treatment, resistance-causing genetic mutations were more frequent in isolates from colistin-treated patients. Distinct mutations were overlooked via the Sanger sequencing method, perhaps because of a masking effect by the colistin-susceptible AB subpopulation of CR-AB isolates lacking genetic mutations. However, modified lipid A analysis revealed colistin resistance peaks, despite the population heterogeneity, and peak levels were significantly different between the groups. Conclusions Although prior colistin use did not induce clinical or susceptibility differences, we demonstrated that identification of CR-AB by sequencing is insufficient. We propose that population heterogeneity has a masking effect, especially in colistin non-treated patients; therefore, accurate testing methods reflecting physiological alterations of the bacteria, such as phosphoethanolamine-modified lipid A identification by matrix-assisted laser desorption ionization-time of flight, should be employed.
- Subjects :
- Acinetobacter baumannii
Male
0301 basic medicine
Resistance
Clinical Biochemistry
Pathogenesis
Drug resistance
Population heterogeneity
Colistin resistance
Lipid A
Anti-Infective Agents
polycyclic compounds
Medicine
Sanger sequencing
biology
Mortality rate
General Medicine
Middle Aged
Anti-Bacterial Agents
Electrophoresis, Gel, Pulsed-Field
Lipid A analysis
symbols
Original Article
Female
lipids (amino acids, peptides, and proteins)
Acinetobacter Infections
medicine.drug
Adult
DNA, Bacterial
Adolescent
030106 microbiology
Microbial Sensitivity Tests
Microbiology
Young Adult
03 medical and health sciences
symbols.namesake
Drug Resistance, Bacterial
Humans
Aged
Colistin
business.industry
Biochemistry (medical)
biochemical phenomena, metabolism, and nutrition
bacterial infections and mycoses
biology.organism_classification
Clinical Microbiology
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
bacteria
business
Bacteria
Multilocus Sequence Typing
Subjects
Details
- ISSN :
- 22343814 and 22343806
- Volume :
- 38
- Database :
- OpenAIRE
- Journal :
- Annals of Laboratory Medicine
- Accession number :
- edsair.doi.dedup.....d6b1793381abd7c06050eafb99818b2f